Da Song Wang

Da Song Wang

Directeur/Membre du Conseil chez ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.
57 ans
Health Technology
Finance
Consumer Services

Profil

Da Song Wang is currently a Non-Executive Director at Beijing QL Biopharmaceutical Co., Ltd. since 2026, a Non-Executive Director at Zylox-Tonbridge Medical Technology Co., Ltd. since 2021, a Non-Executive Director at Lupeng Pharmaceutical Ltd. since 2025, and a Partner at OrbiMed Advisors Private Equity since 2019.
Former positions include Non-Executive Director at 3SBio, Inc. from 2017 to 2019, Managing Director & Head-APAC Healthcare at Credit Suisse (Hong Kong) Ltd., Executive Director at Morgan Stanley Capital Partners (Private Equity) from 2007 to 2011, Managing Director at UBS Asset Management (Infrastructure) from 2011 to 2014, Non-Executive Director at EC Healthcare from 2020 to 2021, and Non-Executive Director at Apollomics, Inc. (United States).
Education includes an undergraduate degree from the University of Southern Maine in 1991, a doctorate from The Johns Hopkins University in 1997, and an MBA from New York University in 2000.

Postes actifs de Da Song Wang

SociétésPosteDébut
ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD. Directeur/Membre du Conseil 13/10/2020
Private Equity Investor 01/09/2019
Directeur/Membre du Conseil 01/02/2026

Anciens postes connus de Da Song Wang

SociétésPosteFin
EC HEALTHCARE Directeur/Membre du Conseil 19/07/2021
3SBIO INC. Directeur/Membre du Conseil 08/10/2019
Private Equity Investor 01/07/2014
Private Equity Investor 01/05/2011
Corporate Officer/Principal -
Voir l'expérience en détail de Da Song Wang

Formation de Da Song Wang

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

95

Relations au 1er degré

12

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées12

Health Technology

Finance

Consumer Services

Consumer Services

Consumer Services

Finance

Finance

Finance

Health Services

Health Technology

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Da Song Wang